Market Cap | 54.75M | P/E | - | EPS this Y | 10.80% | Ern Qtrly Grth | - |
Income | -91.89M | Forward P/E | -0.56 | EPS next Y | 8.90% | 50D Avg Chg | -14.00% |
Sales | 2.72M | PEG | -0.04 | EPS past 5Y | - | 200D Avg Chg | -53.00% |
Dividend | N/A | Price/Book | 0.23 | EPS next 5Y | 11.10% | 52W High Chg | -84.00% |
Recommedations | 2.70 | Quick Ratio | 7.95 | Shares Outstanding | 2.50M | 52W Low Chg | 3.00% |
Insider Own | 13.90% | ROA | -24.28% | Shares Float | 1.57M | Beta | 1.35 |
Inst Own | 54.54% | ROE | -51.61% | Shares Shorted/Prior | 107.01K/13.96K | Price | 0.76 |
Gross Margin | -41.06% | Profit Margin | - | Avg. Volume | 317,387 | Target Price | 9.47 |
Oper. Margin | -3,094.17% | Earnings Date | Aug 13 | Volume | 180,952 | Change | -3.80% |
Singular Genomics Systems, Inc., a life science technology company, develops next generation sequencing and spatial multiomics technology for researchers and clinicians to advance science and medicine. The company is involved in the developing of G4, consisting of G4 instrument and associated consumables for various applications, such as max read kits for single cell sequencing, rare variant detection with high-definition sequencing, gene fusion detection with ring-seq, and extended range sequencing; and PX instrument and associated consumables focusing on the single cell and spatial analysis markets. Singular Genomics Systems, Inc. was incorporated in 2016 and is based in San Diego, California.
Goldman Sachs | Neutral | Jul 9, 24 |
Goldman Sachs | Neutral | May 15, 24 |
UBS | Neutral | Mar 20, 24 |
Goldman Sachs | Neutral | Jan 23, 24 |
Goldman Sachs | Neutral | Jan 22, 24 |
Goldman Sachs | Neutral | Aug 10, 23 |
Goldman Sachs | Neutral | Nov 8, 22 |
UBS | Neutral | Aug 17, 22 |
B of A Securities | Underperform | Aug 10, 22 |
Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
---|---|---|---|---|---|---|---|---|
Glezer Eli N. | Chief Scientific Off.. Chief Scientific Officer | Nov 16 | Buy | 0.4282 | 200,000 | 85,640 | 4,570,000 | 11/20/23 |
Kamdar Kim P. | Director Director | Aug 11 | Sell | 0.57 | 631,648 | 360,039 | 3,763,985 | 08/15/23 |
Glezer Eli N. | Chief Scientific Off.. Chief Scientific Officer | May 17 | Buy | 0.8172 | 170,000 | 138,924 | 4,355,000 | 05/18/23 |
Glezer Eli N. | Chief Scientific Off.. Chief Scientific Officer | Dec 12 | Buy | 2.00 | 50,000 | 100,000 | 4,185,000 | 12/13/22 |
BARKER DAVID L | Director Director | Jul 07 | Option | 0.63 | 60,000 | 37,800 | 60,000 | 07/11/22 |
Pellini Michael J | Director Director | May 31 | Option | 0.36 | 154,939 | 55,778 | 254,228 | 06/07/22 |
Pellini Michael J | Director Director | May 18 | Buy | 3.30 | 26,834 | 88,552 | 99,289 | 05/19/22 |